Qi Kaiyan, Li Guangqi, Jiang Yuanjun, Tan Xuexin, Qiao Qiao
Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China.
Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Front Genet. 2024 Jul 12;15:1342306. doi: 10.3389/fgene.2024.1342306. eCollection 2024.
Squamous cell carcinomas (SCCs) across different anatomical locations possess common molecular features. Recent studies showed that stromal cells may contribute to tumor progression and metastasis of SCCs. Limited by current sequencing technology and analysis methods, it has been difficult to combine stroma expression profiles with a large number of clinical information.
With the help of transfer learning on the cell line, single-cell, and bulk tumor sequencing data, we identified and validated 2 malignant gene patterns (V1 and V5) expressed by stromal cells of SCCs from head and neck (HNSCC), lung (LUSC), cervix (CESC), esophagus, and breast.
Pattern V5 reflected a novel malignant feature that explained the mixed signals of HNSCC molecular subtypes. Higher expression of pattern V5 was related to shorter PFI with gender and cancer-type specificity. The other stromal gene pattern V1 was associated with poor PFI in patients after surgery in all the three squamous cancer types (HNSCC = 0.0055, LUSC = 0.0292, CESC = 0.0451). Cancer-associated fibroblasts could induce HNSCC cancer cells to express pattern V1. Adjuvant radiotherapy may weaken the effect of high V1 on recurrence and metastasis, depending on the tumor radiosensitivity.
Considering the prognostic value of stromal gene patterns and its universality, we suggest that the genetic subtype classification of SCCs may be improved to a new system that integrates both malignant and non-malignant components.
不同解剖部位的鳞状细胞癌(SCC)具有共同的分子特征。最近的研究表明,基质细胞可能有助于SCC的肿瘤进展和转移。受当前测序技术和分析方法的限制,很难将基质表达谱与大量临床信息相结合。
借助对细胞系、单细胞和肿瘤组织测序数据的迁移学习,我们鉴定并验证了2种由头颈部(HNSCC)、肺(LUSC)、宫颈(CESC)、食管和乳腺的SCC基质细胞表达的恶性基因模式(V1和V5)。
模式V5反映了一种新的恶性特征,解释了HNSCC分子亚型的混合信号。模式V5的高表达与具有性别和癌症类型特异性的较短无进展生存期(PFI)相关。另一种基质基因模式V1与所有三种鳞状细胞癌类型(HNSCC = 0.0055,LUSC = 0.0292,CESC = 0.0451)患者术后的不良PFI相关。癌症相关成纤维细胞可诱导HNSCC癌细胞表达模式V1。辅助放疗可能会削弱高V1对复发和转移的影响,这取决于肿瘤的放射敏感性。
考虑到基质基因模式的预后价值及其普遍性,我们建议将SCC的基因亚型分类改进为一个整合恶性和非恶性成分的新系统。